Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UKNOWN
UNII: 78LXD26OX3

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiopoietin-2 inhibitor Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Glioblastoma 2 D005909 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Carcinoma 1 D002277 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594470
FDA SRS 78LXD26OX3